AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 141 min read$TRU

Achanta Venkat sold $1.8M of TRU

Achanta Venkat (EVP, Chief Tech, Data & Analy.) sold 23,287 shares of TransUnion (TRU) at $77.00 ($1.79M total) on 2026-09-10.

Original reporting
SEC EDGAR · Achanta Venkat
Published Sep 14, 2026, 10:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 10:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$TRU
Bearish
medium confidence
Mentioned
$TRU
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUBearishLow
01

Why it matters

The sale represents a fresh insider move, offering a data point for sentiment models.

02

Market read

Provides a primary source of insider activity for TransUnion, useful for short-term sentiment.

03

What to watch

Sale could be part of a pre-arranged tax strategy, not sentiment-driven.

Relevance 6/10Novelty 7/10Timing: post-market filing

Background

Form 4 filings disclose insider transactions; traders monitor for signals.

Company-level read

Ticker impact

$TRUBearishMedium confidence
Context

EVP sold 23,287 shares for $1.79M via open-market transaction.

Expected impact

Possible modest dip in near-term trading.

Evidence & confidence

Sale size is notable for an executive but not large enough to cause major move.

Market effects

Sector

May prompt scrutiny of other tech/data executives' holdings.

Regional

Limited to US equity markets.

Global

Low

Counterpoint

What could challenge this read

Insider may be diversifying; sale does not necessarily indicate company weakness.

Key entities

  • Officer
    Achanta Venkat

    EVP, Chief Tech, Data & Analytics at TransUnion

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

TRU insider trading history →

Related articles

OCT 27
$TRUHighAI 8/10

TransUnion (TRU) (Q3 2026) Earnings Call Highlights: Revenue and EPS Beat Guidance

TransUnion (TRU) reported Q3 2026 earnings beating guidance with 8% revenue growth and 14% EPS growth. International business grew 10%, led by India and Latin America. The company reduced its leverage ratio and increased share repurchase authorization. However, rising interest rates are expected to slow mortgage volumes and auto affordability, leading to a sequential deceleration in revenue growth to 3-6% in Q4. Legal and regulatory expenses also contributed to margin contraction.

finance.yahoo.com2 min
OCT 27
$TRUHighAI 8/10

TransUnion (TRU) Q3 2026 Earnings Call Transcript

TransUnion (TRU) reported Q3 2026 organic revenue growth of 8%, with adjusted EPS up 14%. U.S. Markets revenue rose 7%, while international revenue grew 10%, led by India and Latin America. The company repurchased $126M in shares and raised its repurchase authorization by $1B. Despite economic uncertainties, TRU raised its full-year guidance, expecting 8-9% revenue growth and 12-13% adjusted EPS growth.

finance.yahoo.com3 min
OCT 27
$TRUMed

TransUnion Q3 2026 Earnings Call Summary

TransUnion reported Q3 2026 earnings, highlighting 18% growth in India and Latin America, 13% auto growth, and 10% international growth. The company expects full-year share repurchases of $500M and plans to expand its OneTru platform globally. Management noted resilience in US Financial Services despite inflation and higher interest rates, and provided guidance for Q4, including potential impacts from regulatory changes and market softening.

finance.yahoo.com3 min
OCT 27
$TRUHighAI 8/10

TransUnion Q3 2026 slides: insurance drives growth amid margin pressure

TransUnion (TRU) reported Q3 2026 earnings with revenue of $1.31B, matching estimates, and EPS of $1.25, beating forecasts. Revenue grew 8% organically, driven by insurance and international markets. However, adjusted EBITDA margin contracted by 90 basis points to 35.4%. The company raised full-year guidance, expecting 8-9% revenue growth and 12-13% EPS growth. Shares fell 2.19% in premarket trading.

investing.com2 min